It may be supplied as a prefilled pen or vial, and you can use it at any time of day, with or without food
While some muscle loss may occur, the majority of the weight loss is fat loss. This is not the first study to show that weight loss from the use of GLP-1 medications may be lower than we think
Similar content being viewed by others 1 Introduction Semaglutide (US brand name Ozempic or Wegovy), a Glucagon-like peptide-1 receptor (GLP-1R) agonist containing the active ingredient semaglutide, is approved by the Food and Drug Administration for its potential therapeutic role in obesity and diabetes mellitus (DM) similar to other agonists within the GLP-1R family such as liraglutide
Your rate of weight loss and the amount will depend on your body, diet, activity level, and other factors
A notable, well-known effect is appetite stimulation through ghrelin-receptor activity